May 10 (Reuters) - Hofseth Biocare ASA HOFBC.OL :
* HOFSETH BIOCARE HAD OPERATING REVENUES OF NOK 14.7M
(14.8M) IN
Q1 OF 2019
* COST OF GOODS SOLD AMOUNTED TO NOK 10.9M (12.3M) IN
PERIOD.
OPERATIONAL PROFIT (EBITDA) FOR Q1 2019 WAS NEGATIVE NOK 12.9M
(14.9M)
* EXPECT PROCESSED RAW MATERIAL TO CONTINUE INCREASING
DURING 2019
* OPERATIONAL PROFIT (EBITDA) FOR Q1 2019 WAS NEGATIVE NOK
12.9M
(14.9M).
* QTRLY EARNINGS PER SHARE (NOK) -0.07
* CASH & CASH EQUIVALENTS FELL BY NOK 12.1M IN QUARTER,
LEAVING
TOTAL HOLDING OF CASH & CASH EQUIVALENTS AT NOK 36.5M BY END OF
PERIOD
Source text for Eikon: ID:nGNEc5vXxv
Further company coverage: HOFBC.OL
((Reuters.Briefs@thomsonreuters.com;))